Abstract

New complexes of 6-amino-4-hydroxy-2-thiopyrimidine (Hahtp), [Zn(ahtp)2(H2O)2], [Zn(ahtp)2(PPh3)(H2O)], [Zn(Hahtp)(bpy)Cl2], [Pd(phen)(ahtp]Cl, [Pd(Hahtp)(PPh3)2]Cl2, [Ag(ahtp)(H2O)2], [Ag(ahtp)(PPh3)(H2O)], [Ag(ahtp)L] (L=bpy, phen), have been synthesized and characterized on the basis of spectral (IR, 1H-NMR, ESI-mass and UV–visible), elemental analysis, thermal and molar conductivity measurements. Three modes of chelations have been observed for Hahtp; as a neutral bidentate ligand through cyclic nitrogen and thione sulfur atoms, mononegative bidentate ligand through either the deprotonated cyclic nitrogen and thione sulfur atoms or the deprotonated hydroxy and cyclic nitrogen atoms; all forming four-membered chelating rings. The free Hahtp and its complexes, [Zn(ahtp)2(H2O)2], [Zn(Hahtp)2(PPh3)(H2O)], [Zn(Hahtp)(bpy)Cl2], [Pd(phen)(Hahtp]Cl and [Ag(Hahtp)(PPh3)(H2O)] have been tested against the human breast cancer MDA-MB231 cell line. The [Ag(ahtp)(PPh3)(H2O)] complex exhibits the highest efficacy with a mean IC50 value of 4.7μM.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.